Icahn School of Medicine at Mount Sinai Clinical Trials
Sponsors / Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai is listed as the lead sponsor on 669 clinical trials registered with ClinicalTrials.gov. 138 trials are actively recruiting participants, 24 remain active without open enrollment, and 395 have concluded. 73 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 454,710 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
Termination reasons: Recruitment42% · Other33% · Funding11% · Efficacy8% · Safety3% · PI/or_Site1% · Regulatory1%
Recent Terminations
- NCT06985342 Stopped Feb 2026Migraine Headaches"Study closing at current site. Study to start as new at different site."
- Peripartum Anemia"Under enrollment"
- CTCL"No significant improvement in disease as graded by our assessments."
- Pleural Disease"interim, lack of obvious benefit"
- Papulopustular Rosacea"The study ended early because interim analysis showed no significant difference between the active and placebo arms."
- Chronic Pain"Sponsor halted funding"
- Cardiovascular Health"Not meeting recruitment targets"
- Cognitive Impairment"Study enrollment closed due to low enrollment."
- Avoidant Restrictive Food Intake Disorder"Lack of agreement for risk mitigation plan"
- Diabetes"Site decided not to continue"
Active Trials (24 total)
- NCT06655857
- NCT05518500
- NCT07493317
- NCT01782703
- NCT07219563
- NCT07548385
- NCT05911568
- NCT04983875
- NCT03144765
- NCT06619327
- Long Covid PHASE2NCT06511063
- NCT07207200
- NCT07394608
- NCT06771167
- NCT07455201
- NCT07318480
- NCT05197309
- NCT03963817
- Alopecia Areata PHASE2NCT05866562
- HIV PHASE1/PHASE2NCT04353778